source
- Kelun-Biotech reports first-line success of Merck-partnered ADC sacituzumab tirumotecan in ChinaKelun-Biotech announced that its antibody‑drug conjugate sacituzumab tirumotecan, developed in partnership with Merck, achieved its primary efficacy endpoints when used as a first‑line therapy in a…
- Arrow International issues correction for convenience kits containing recalled saline, lidocaine and bupivacaineArrow International, a Teleflex subsidiary, sent a correction notice to customers about certain convenience kits. The kits contain 10 mL saline ampules, lidocaine and bupivacaine. The FDA classifi…